TSM
TAIWAN SEMICONDUCTOR-SP ADRData as of 2026 Q2 (06-30) · 13F snapshot
Common-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Andreas Halvorsen | $1.51B | 4.3% | Trim |
| Leopold Aschenbrenner | $1.27B | 6.3% | Big add |
| David Tepper | $787.99M | 10.5% | Add |
| Izzy Englander | $760.50M | 0.5% | Trim |
| Dodge & Cox | $688.07M | 0.4% | Add |
| Paul Tudor Jones | $653.94M | 2.7% | Big add |
| Renaissance Technologies | $405.50M | 0.6% | Add |
| Alex Sacerdote | $281.72M | 2.3% | Trim |
| Stanley Druckenmiller | $281.61M | 6.5% | Add |
| George Soros | $249.37M | 4.1% | Hold |
| Cathie Wood | $230.33M | 1.5% | Trim |
| Dan Loeb | $219.68M | 4.7% | Big add |
| Terry Smith | $196.51M | 4.3% | Big add |
| Dan Bin | $65.57M | 4.0% | Trim |
| Greenwoods Asset Management | $30.82M | 1.8% | Hold |
| Zhang Lei | $7.41M | 0.9% | Hold |
| Joel Greenblatt | $3.60M | 0.0% | Hold |
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $4.65B | — | — |
| Ken GriffinCALL | $3.73B | — | — |
| Paul Tudor JonesPUT | $1.05B | — | — |
| Izzy EnglanderPUT | $691.00M | — | — |
| Izzy EnglanderCALL | $239.64M | — | — |
| Paul Tudor JonesCALL | $138.69M | — | — |
| George SorosPUT | $81.19M | — | — |
| Leopold AschenbrennerCALL | $23.88M | — | — |
| Steven CohenCALL | $20.34M | — | — |
| Steven CohenPUT | $14.04M | — | — |
Insider Trading
Officers · directors · Form 4Chun-Hsien Lee
SVP
Buy$4.0K52 @ $76.20Traded 2026-09-07Filed 2026-09-09Juiping Chuang
VP
Buy$3.8K50 @ $76.20Traded 2026-09-07Filed 2026-09-09Shien-Yang Wu
SVP
Buy$4.3K57 @ $76.20Traded 2026-09-07Filed 2026-09-09Shyue-Shyh Lin
VP
Buy$3.4K44 @ $76.20Traded 2026-09-07Filed 2026-09-09Kuo-Chin Hsu
VP
Buy$4.2K55 @ $76.20Traded 2026-09-07Filed 2026-09-09Yung-Chin Hou
SVP and Deputy Co-COO
Buy$4.6K61 @ $76.20Traded 2026-09-07Filed 2026-09-09Choh Fei Yeap
SVP
Buy$4.1K54 @ $76.20Traded 2026-09-07Filed 2026-09-09Yuh-Jier Mii
EVP and Co-COO
Buy$5.4K71 @ $76.20Traded 2026-09-07Filed 2026-09-09Bor-Zen Tien
VP
Buy$3815 @ $76.20Traded 2026-09-07Filed 2026-09-09Chris Horng-Dar Lin
VP and CIO
Buy$3.6K47 @ $76.20Traded 2026-09-07Filed 2026-09-09Syun-Ming Jang
VP
Buy$3.7K49 @ $76.20Traded 2026-09-07Filed 2026-09-09Yuan-Ko Hwang
VP
Buy$3.0K40 @ $76.20Traded 2026-09-07Filed 2026-09-09Jen-Chau Huang
SVP and CFO
Buy$2.3K30 @ $76.20Traded 2026-09-07Filed 2026-09-09Yao-Ching Ku
VP
Buy$3.6K47 @ $76.20Traded 2026-09-07Filed 2026-09-09Yi-Huang Wu
VP
Buy$3.0K40 @ $76.20Traded 2026-09-07Filed 2026-09-09Chue-San Yoo
VP
Buy$4.0K53 @ $76.20Traded 2026-09-07Filed 2026-09-09Kevin Xiaoqiang Zhang
SVP and Deputy Co-COO
Buy$4.6K61 @ $76.20Traded 2026-09-07Filed 2026-09-09Lipen Yuan
VP
Buy$3.1K41 @ $76.20Traded 2026-09-07Filed 2026-09-09Che-Chia Wei
Chairman and CEO
Buy$11.4K149 @ $76.20Traded 2026-09-07Filed 2026-09-09Bor-Zen Tien
VP
Buy$3.3K43 @ $76.20Traded 2026-09-07Filed 2026-09-09Ying-Lang Wang
SVP
Buy$4.1K54 @ $76.20Traded 2026-09-07Filed 2026-09-09Chin-Sheng Lu
VP
Buy$2.9K38 @ $76.20Traded 2026-09-07Filed 2026-09-09Lee-Chung Lu
VP
Buy$3.9K51 @ $76.20Traded 2026-09-07Filed 2026-09-09Shu-Hua Fang
SVP and GC
Buy$4.3K56 @ $76.20Traded 2026-09-07Filed 2026-09-09
Insider transactions are public SEC Form 4 disclosures (company officers, directors, 10% owners), for research only — not investment advice.
ARK ETF holdings
Cathie Wood · daily- ARKQweight in fund3.82%$72.63M
- ARKWweight in fund2.24%$43.17M
- ARKXweight in fund1.93%$14.69M
- ARKKweight in fund1.01%$86.05M
ARK publishes full ETF holdings daily (SEC Rule 6c-11). Line shows ARK's total shares held over time (not price); markers are buy/sell days. Derived from public CSVs — research only, not investment advice.
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.